Insider filing · CROX

John B Replogle bought $252K of Crocs (CROX)

Executed Oct 30 2024, disclosed Oct 30 2024, the same day.

Over the 21 trading sessions from the disclosed entry session (Oct 30 2024), the stock returned -4.1% (delay-adjusted); from the execution session (Oct 30 2024), -4.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

JR John B Replogle Director profile →

John B Replogle (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Crocs, Inc. (CROX). Across 1 priced purchase filing, the average 21-session return was +17.0% from execution and +17.7% from disclosure (delay-adjusted; derived). The largest single filing was $224K of CROX (3,000 sh × $74.50, as filed), executed Nov 11 2025.

CROX Crocs, Inc. CROX · Consumer Cyclical · 14 filings in 24 months ticker →

Consumer Cyclical · Crocs, Inc. together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and…

More Consumer Cyclical filings→ Insider filings, newest first→ View the original filing at www.sec.gov→